AltMountain

Genesis Life Sciences Fund LP

New York, NY · CIK 1545731
Status: no Form D since Mar 2012. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Genesis Life Sciences Fund LP is a hedge fund based in New York, New York. According to its most recent Form D, filed Mar 30, 2012, the fund has sold $14,267,666 of interests to 29 investors since its first sale in Oct 2010. The minimum investment it accepts from an outside investor is $250,000. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. Related persons named in the filing include Ethan Benovitz; Jaime Hartman; Daniel Saks.

Performance

No returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.

Is this your fund? Report your monthly returns · How performance works

Total raised
$14,267,666Cumulative sales reported on Form D
Investors
29
First sale
Oct 15, 2010
Minimum investment
$250,000
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Other exemption
Key people and entities
Ethan Benovitz; Jaime Hartman; Daniel Saks
Latest Form D
Mar 30, 2012

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction

Questions about Genesis Life Sciences Fund LP

What is the minimum investment for Genesis Life Sciences Fund LP?

According to its latest Form D, filed Mar 30, 2012, the minimum investment Genesis Life Sciences Fund LP accepts from an outside investor is $250,000.

Who can invest in Genesis Life Sciences Fund LP?

Genesis Life Sciences Fund LP is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1).

How much has Genesis Life Sciences Fund LP raised?

Genesis Life Sciences Fund LP reports $14,267,666 sold from 29 investors on its Form D filed Mar 30, 2012. This is cumulative sales since the offering began, not current assets or performance.

Where is Genesis Life Sciences Fund LP based?

Genesis Life Sciences Fund LP is based in New York, New York.

When did Genesis Life Sciences Fund LP launch?

Genesis Life Sciences Fund LP reports its first sale in Oct 2010.

Size compared with every hedge fund

Raised more than 27% of the 2,527 hedge funds based in New York, and more than 25% of all 10,134 that report sales.

More hedge funds in New York

Similar-size hedge funds in New York

All hedge funds in New York